Ono Pharmaceutical Co Ltd
TSE:4528
Ono Pharmaceutical Co Ltd
TSE:4528
Price:
1 606
JPY
-0.12%
Market Closed
Market Cap:
754.2B
JPY
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
Ono Pharmaceutical Co Ltd
1606
-2 (-0.12%)
| 52 Week Range |
1 606
2 681
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Ono Pharmaceutical Co Ltd
Balance Sheet
Balance Sheet Decomposition
Ono Pharmaceutical Co Ltd
Ono Pharmaceutical Co Ltd
| Current Assets | 401.4B |
| Cash & Short-Term Investments | 181.1B |
| Receivables | 137.3B |
| Other Current Assets | 83B |
| Non-Current Assets | 645B |
| Long-Term Investments | 125.4B |
| PP&E | 107.1B |
| Intangibles | 366.8B |
| Other Non-Current Assets | 45.7B |
| Current Liabilities | 124.7B |
| Accounts Payable | 58.9B |
| Other Current Liabilities | 65.8B |
| Non-Current Liabilities | 139.3B |
| Long-Term Debt | 128.8B |
| Other Non-Current Liabilities | 10.5B |
Balance Sheet
Ono Pharmaceutical Co Ltd
Ono Pharmaceutical Co Ltd
Currency: JPY
| Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
25 284
|
35 516
|
146 323
|
65 273
|
59 981
|
69 005
|
61 045
|
69 112
|
96 135
|
166 141
|
|
| Cash Equivalents |
25 284
|
35 516
|
146 323
|
65 273
|
59 981
|
69 005
|
61 045
|
69 112
|
96 135
|
166 141
|
|
| Short-Term Investments |
23 566
|
22 383
|
18 379
|
20 503
|
11 487
|
31 414
|
43 930
|
47 857
|
68 154
|
38 454
|
|
| Total Receivables |
120 898
|
137 012
|
73 255
|
81 196
|
76 285
|
76 834
|
84 269
|
99 788
|
114 396
|
136 066
|
|
| Accounts Receivables |
35 329
|
56 436
|
68 131
|
70 391
|
67 861
|
68 957
|
74 085
|
92 697
|
108 360
|
129 007
|
|
| Other Receivables |
85 569
|
80 576
|
5 124
|
10 805
|
8 424
|
7 877
|
10 184
|
7 091
|
6 036
|
7 059
|
|
| Inventory |
25 805
|
23 232
|
25 334
|
31 290
|
32 821
|
32 906
|
39 151
|
41 817
|
44 814
|
48 629
|
|
| Other Current Assets |
2 312
|
5 430
|
7 742
|
11 202
|
14 043
|
15 063
|
19 247
|
22 692
|
21 602
|
24 306
|
|
| Total Current Assets |
197 865
|
223 573
|
271 033
|
209 464
|
194 617
|
225 222
|
247 642
|
281 266
|
345 101
|
413 596
|
|
| PP&E Net |
70 754
|
80 094
|
83 659
|
94 321
|
108 870
|
114 628
|
113 866
|
112 131
|
108 420
|
104 752
|
|
| PP&E Gross |
70 754
|
80 094
|
83 659
|
94 321
|
108 870
|
114 628
|
113 866
|
112 131
|
108 420
|
104 752
|
|
| Accumulated Depreciation |
78 807
|
79 641
|
81 218
|
82 539
|
84 948
|
88 766
|
93 905
|
100 787
|
107 370
|
114 005
|
|
| Intangible Assets |
33 913
|
38 324
|
45 237
|
55 715
|
63 059
|
66 436
|
68 285
|
64 734
|
69 134
|
57 288
|
|
| Long-Term Investments |
213 185
|
183 378
|
176 687
|
188 919
|
171 589
|
137 778
|
146 908
|
125 154
|
123 423
|
121 262
|
|
| Other Long-Term Assets |
8 871
|
15 081
|
40 845
|
60 807
|
116 921
|
129 380
|
168 727
|
155 918
|
236 359
|
216 770
|
|
| Total Assets |
524 588
N/A
|
540 450
+3%
|
617 461
+14%
|
609 226
-1%
|
655 056
+8%
|
673 444
+3%
|
745 428
+11%
|
739 203
-1%
|
882 437
+19%
|
913 668
+4%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
3 779
|
9 793
|
7 128
|
5 623
|
6 297
|
6 398
|
7 640
|
8 991
|
8 033
|
10 742
|
|
| Short-Term Debt |
26
|
37
|
26
|
84
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
261
|
291
|
398
|
308
|
435
|
2 188
|
2 023
|
2 301
|
2 490
|
2 310
|
|
| Other Current Liabilities |
30 931
|
42 073
|
75 381
|
62 454
|
76 418
|
82 743
|
84 070
|
54 634
|
112 406
|
90 572
|
|
| Total Current Liabilities |
34 997
|
52 194
|
82 933
|
68 469
|
83 150
|
91 329
|
93 733
|
65 926
|
122 929
|
103 624
|
|
| Long-Term Debt |
338
|
534
|
553
|
320
|
1 765
|
6 173
|
7 030
|
6 501
|
6 678
|
6 552
|
|
| Deferred Income Tax |
1 156
|
885
|
881
|
1 016
|
1 053
|
1 059
|
1 052
|
1 009
|
983
|
1 013
|
|
| Minority Interest |
4 638
|
4 862
|
5 101
|
5 228
|
5 386
|
5 538
|
5 610
|
5 768
|
5 944
|
5 644
|
|
| Other Liabilities |
12 884
|
10 582
|
8 883
|
9 802
|
6 352
|
6 861
|
3 870
|
4 093
|
4 035
|
3 875
|
|
| Total Liabilities |
54 013
N/A
|
69 057
+28%
|
98 351
+42%
|
84 835
-14%
|
97 706
+15%
|
110 960
+14%
|
111 295
+0%
|
83 297
-25%
|
140 569
+69%
|
120 708
-14%
|
|
| Equity | |||||||||||
| Common Stock |
17 358
|
17 358
|
17 358
|
17 358
|
17 358
|
17 358
|
17 358
|
17 358
|
17 358
|
17 358
|
|
| Retained Earnings |
449 690
|
452 983
|
492 237
|
459 985
|
499 088
|
524 605
|
62 299
|
644 754
|
709 890
|
768 183
|
|
| Additional Paid In Capital |
17 080
|
17 103
|
17 144
|
17 175
|
17 202
|
17 229
|
17 231
|
17 241
|
17 080
|
17 458
|
|
| Unrealized Security Profit/Loss |
44 583
|
0
|
51 035
|
67 416
|
61 170
|
47 567
|
61 412
|
49 535
|
49 529
|
49 300
|
|
| Treasury Stock |
59 308
|
0
|
59 382
|
38 148
|
38 151
|
44 737
|
44 705
|
74 683
|
54 161
|
63 233
|
|
| Other Equity |
1 172
|
813
|
718
|
605
|
683
|
462
|
520 538
|
1 701
|
2 172
|
3 894
|
|
| Total Equity |
470 575
N/A
|
471 393
+0%
|
519 110
+10%
|
524 391
+1%
|
557 350
+6%
|
562 484
+1%
|
634 133
+13%
|
655 906
+3%
|
741 868
+13%
|
792 960
+7%
|
|
| Total Liabilities & Equity |
524 588
N/A
|
540 450
+3%
|
617 461
+14%
|
609 226
-1%
|
655 056
+8%
|
673 444
+3%
|
745 428
+11%
|
739 203
-1%
|
882 437
+19%
|
913 668
+4%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
530
|
530
|
530
|
514
|
514
|
499
|
499
|
488
|
488
|
470
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
